This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanofi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Charlotte Lahoute
Introduction
Charlotte Lahoute is an accomplished inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. Her work focuses on addressing critical health issues, including autoimmune diseases.
Latest Patents
Charlotte holds a patent for CD28/OX40 bispecific antibodies. This patent describes multispecific binding proteins that include a first antigen binding domain (ABD) with binding specificity to CD28 and a second ABD with binding specificity to OX40. The patent also outlines methods for treating autoimmune diseases using these innovative proteins. She has 1 patent to her name.
Career Highlights
Charlotte is currently employed at Sanofi, a leading global healthcare company. Her role involves research and development in the field of immunology, where she applies her expertise to create novel therapeutic solutions.
Collaborations
Charlotte has collaborated with notable colleagues, including Gerald Beste and Yanik Bruynooghe, to advance her research and innovations in the field.
Conclusion
Charlotte Lahoute's contributions to biotechnology and her innovative work on bispecific antibodies highlight her role as a leading inventor in her field. Her dedication to improving treatments for autoimmune diseases showcases the impact of her research on global health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile